Target intelligence / Profile preview

ZNF516 divergent transcript (ZNF516-DT)

Target
ZNF516-DT
Molecular classification
Long non-coding RNA (lncRNA), Other (not a receptor, enzyme, transporter, transcription factor, nor a traditional 'protein target')
01

Overview

ZNF516 divergent transcript (ZNF516-DT) is a human long non-coding RNA gene, previously known as C18orf65. It is classified as a divergent transcript, defined as a lncRNA situated within 300-500 nucleotides of a protein-coding gene (in this case, ZNF516). It is annotated as a putative uncharacterized protein, but there is no evidence supporting its translation into a functional protein product, nor a defined biological role. There are no data indicating it acts as a therapeutic target, nor any disease, biomarker, or drug information at this time. Do not confuse with the protein-coding gene ZNF516 (zinc finger protein 516), which is a transcription factor; ZNF516-DT is a distinct non-coding RNA locus adjacent to that gene.

Other names
Putative uncharacterized protein ZNF516-DTC18orf65Chromosome 18 open reading frame 65ZNF516 divergent transcriptZNF516-DT
02

Biological functions

Unknown/poorly characterized for this specific transcriptGenerally, divergent transcripts are lncRNAs located near protein-coding genes and may be involved in regulation of neighboring gene expression
03

Disease associations

No established disease associations or roles based on current data

Beyond the preview

Go deeper on ZNF516 divergent transcript (ZNF516-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF516 divergent transcript (ZNF516-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call